S'abonner

Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract - 23/11/23

Doi : 10.1016/j.jinf.2023.10.009 
Mahdi Moradi Marjaneh a, b, c, , Joseph D. Challenger d, Antonio Salas e, f, g, Alberto Gómez-Carballa e, f, g, Abilash Sivananthan a, Irene Rivero-Calle f, g, h, Gema Barbeito-Castiñeiras i, Cher Y. Foo j, Yue Wu k, Felicity Liew l, Heather R. Jackson a, b, Dominic Habgood-Coote a, b, Giselle D’Souza a, b, Samuel J. Nichols a, b, Victoria J. Wright a, b, Michael Levin a, b, Myrsini Kaforou a, b, Ryan S. Thwaites l, Lucy C. Okell d, Federico Martinón-Torres f, g, h, Aubrey J. Cunnington a, b,

on behalf of the PERFORM Consortium1

  Personalised Risk Assessment in Febrile Illness to Optimise Real-Life Management (PERFORM), London, UK.

GEN-COVID Study Group (http://gencovid.eu)

a Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK 
b Centre for Paediatrics and Child Health, Imperial College London, London, UK 
c Section of Virology, Department of Infectious Diseases, Imperial College London, London, UK 
d Medical Research Council Centre for Global Infections Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, London, UK 
e Unidade de Xenética, Instituto de Ciencias Forenses, Facultade de Medicina, Universidade de Santiago de Compostela, and GenPoB Research Group, Instituto de Investigación Sanitaria (IDIS), Hospital Clínico Universitario de Santiago (SERGAS), Galicia, Spain 
f Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, Universidade de Santiago de Compostela, Santiago de Compostela, Galicia, Spain 
g Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER-ES), Madrid, Spain 
h Translational Pediatrics and Infectious Diseases, Department of Pediatrics, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain 
i Servicio de Microbiología y Parasitología, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Galicia, Spain 
j School of Medicine, Imperial College London, London, UK 
k Department of Surgery and Cancer, Imperial College London, St. Mary's Hospital, London, UK 
l National Heart and Lung Institute, Imperial College London, London, UK 

Correspondence to: VC1, Medical School Building, St Mary’s Campus Norfolk Place, London W2 1PG, UK.VC1, Medical School Building, St Mary’s Campus Norfolk PlaceLondonW2 1PGUK⁎⁎Correspondence to: 244, Medical School Building, St Mary’s Campus Norfolk Place, London W2 1PG, UK.244, Medical School Building, St Mary’s Campus Norfolk PlaceLondonW2 1PGUK

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Summary

Objectives

The amount of SARS-CoV-2 detected in the upper respiratory tract (URT viral load) is a key driver of transmission of infection. Current evidence suggests that mechanisms constraining URT viral load are different from those controlling lower respiratory tract viral load and disease severity. Understanding such mechanisms may help to develop treatments and vaccine strategies to reduce transmission. Combining mathematical modelling of URT viral load dynamics with transcriptome analyses we aimed to identify mechanisms controlling URT viral load.

Methods

COVID-19 patients were recruited in Spain during the first wave of the pandemic. RNA sequencing of peripheral blood and targeted NanoString nCounter transcriptome analysis of nasal epithelium were performed and gene expression analysed in relation to paired URT viral load samples collected within 15 days of symptom onset. Proportions of major immune cells in blood were estimated from transcriptional data using computational differential estimation. Weighted correlation network analysis (adjusted for cell proportions) and fixed transcriptional repertoire analysis were used to identify associations with URT viral load, quantified as standard deviations (z-scores) from an expected trajectory over time.

Results

Eighty-two subjects (50% female, median age 54 years (range 3–73)) with COVID-19 were recruited. Paired URT viral load samples were available for 16 blood transcriptome samples, and 17 respiratory epithelial transcriptome samples. Natural Killer (NK) cells were the only blood cell type significantly correlated with URT viral load z-scores (r = −0.62, P = 0.010). Twenty-four blood gene expression modules were significantly correlated with URT viral load z-score, the most significant being a module of genes connected around IFNA14 (Interferon Alpha-14) expression (r = −0.60, P = 1e-10). In fixed repertoire analysis, prostanoid-related gene expression was significantly associated with higher viral load. In nasal epithelium, only GNLY (granulysin) gene expression showed significant negative correlation with viral load.

Conclusions

Correlations between the transcriptional host response and inter-individual variations in SARS-CoV-2 URT viral load, revealed many molecular mechanisms plausibly favouring or constraining viral replication. Existing evidence corroborates many of these mechanisms, including likely roles for NK cells, granulysin, prostanoids and interferon alpha-14. Inhibition of prostanoid production and administration of interferon alpha-14 may be attractive transmission-blocking interventions.

Le texte complet de cet article est disponible en PDF.

Graphical Abstract




ga1

Le texte complet de cet article est disponible en PDF.

Highlights

SARS-CoV-2 upper respiratory viral z-scores were correlated with host response.
Negative correlation between viral load and blood NK cells and IFN-α14 module.
Positive correlation between blood prostanoid module and viral load.
Nasal granulysin expression negatively correlated with viral load z-score.
Identifies putative mechanisms favouring and restricting SARS-CoV-2 replication.

Le texte complet de cet article est disponible en PDF.

Abbreviations : AIPL1, C7orf33, CCL4, COL4A4, COVID-19, CpG, Ct value, CYP2F1, FEZ1, GALNT17, GNLY, IFNA14, IFNA2, IFNAR1 and IFNAR2, IFNL3, IFNLR, IL-22, IL22RA2, IL4I1, IPA, ISGs, JAK/STAT, LRT, NK cells, PCA, PTK2, RBP3, RNA-Seq, RORC, SARS-CoV-2, STING1, Th22, TLR9, TUBB1, UGT1A1, URT, VL, WGCNA

Keywords : COVID-19, SARS-CoV-2, Upper respiratory tract, Viral load, Mathematical modelling, Transcriptome, Gene network analysis


Plan


© 2023  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 87 - N° 6

P. 538-550 - décembre 2023 Retour au numéro
Article précédent Article précédent
  • Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys
  • Craig Fenwick, Priscilla Turelli, Yoan Duhoo, Kelvin Lau, Cécile Herate, Romain Marlin, Myriam Lamrayah, Jérémy Campos, Line Esteves-Leuenberger, Alex Farina, Charlène Raclot, Vanessa Genet, Flurin Fiscalini, Julien Cesborn, Laurent Perez, Nathalie Dereuddre-Bosquet, Vanessa Contreras, Kyllian Lheureux, Francis Relouzat, Rana Abdelnabi, Pieter Leyssen, Yves Lévy, Florence Pojer, Roger Le Grand, Didier Trono, Giuseppe Pantaleo
| Article suivant Article suivant
  • Association between acceptance of routine pregnancy vaccinations and COVID-19 vaccine uptake in pregnant patients
  • Laura Ha, Candace Levian, Naomi Greene, Ilona Goldfarb, Anna Hirsch, Mariam Naqvi

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.